Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells.
暂无分享,去创建一个
Iya Khalil | Christina Curtis | Heming Xing | Joe W Gray | Heidi S Feiler | Paul McDonagh | H. Feiler | J. Gray | P. McDonagh | Heming Xing | C. Curtis | R. Gendelman | I. Khalil | O. Mirzoeva | W. Korn | W Michael Korn | Rina Gendelman | Olga K Mirzoeva | Preeti Sarde | Preeti Sarde | J. Gray
[1] Laura M. Heiser,et al. Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition. , 2009, Cancer research.
[2] Jian Jin,et al. Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer , 2012, Cell.
[3] W. Greene,et al. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. , 2004, The Journal of biological chemistry.
[4] Mark J. Smyth,et al. The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.
[5] D. Crossman,et al. Human Tribbles-1 Controls Proliferation and Chemotaxis of Smooth Muscle Cells via MAPK Signaling Pathways* , 2007, Journal of Biological Chemistry.
[6] Y. Hosokawa,et al. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele‐specific expression , 1998, Genes, chromosomes & cancer.
[7] B. Aggarwal,et al. NF-κB and cancer: how intimate is this relationship , 2010, Molecular and Cellular Biochemistry.
[8] H Nojima,et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. , 1994, The EMBO journal.
[9] D. Spandidos,et al. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1 , 2007, Molecular Cancer Therapeutics.
[10] R. Assoian,et al. Transcriptional regulation of the cyclin D1 gene at a glance , 2008, Journal of Cell Science.
[11] P. Kaldis,et al. Cdc2–cyclin E complexes regulate the G1/S phase transition , 2005, Nature Cell Biology.
[12] M. Ermonval,et al. Glycosylation-related genes are variably expressed depending on the differentiation state of a bioaminergic neuronal cell line: implication for the cellular prion protein , 2009, Glycoconjugate Journal.
[13] N. Navaratnam,et al. Regulation of ploidy and senescence by the AMPK‐related kinase NUAK1 , 2010, The EMBO journal.
[14] Kevin A Janes,et al. A biological approach to computational models of proteomic networks. , 2006, Current opinion in chemical biology.
[15] K. Sachs,et al. Causal Protein-Signaling Networks Derived from Multiparameter Single-Cell Data , 2005, Science.
[16] L. Tierney,et al. Accurate Approximations for Posterior Moments and Marginal Densities , 1986 .
[17] S. Ghosh,et al. The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.
[18] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[19] Nir Friedman,et al. Being Bayesian About Network Structure. A Bayesian Approach to Structure Discovery in Bayesian Networks , 2004, Machine Learning.
[20] Juan Mata,et al. Tribbles Coordinates Mitosis and Morphogenesis in Drosophila by Regulating String/CDC25 Proteolysis , 2000, Cell.
[21] A. Blackburn,et al. Abstract 3228: Dichloroacetate reverses the Warburg effect, inhibiting growth and sensitizing breast cancer cells towards apoptosis , 2012 .
[22] M. Barbacid,et al. Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis , 2000, The EMBO journal.
[23] Anja Schindler,et al. A Direct Phenotypic Comparison of siRNA Pools and Multiple Individual Duplexes in a Functional Assay , 2009, PloS one.
[24] M. Leptin,et al. Tribbles, a cell-cycle brake that coordinates proliferation and morphogenesis during Drosophila gastrulation , 2000, Current Biology.
[25] H. Ford,et al. On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics , 2013, Oncogene.
[26] L. Pfeffer,et al. NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.
[27] S. Akira,et al. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages , 2013, Nature.
[28] Jeffrey L. Wrana,et al. High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer , 2013, Proceedings of the National Academy of Sciences.
[29] G. Sethi,et al. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. , 2010, Biochimica et biophysica acta.
[30] S. Blacklow,et al. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia. , 2010, Blood.
[31] Holger Fröhlich,et al. Large scale statistical inference of signaling pathways from RNAi and microarray data , 2007, BMC Bioinformatics.
[32] M. Pagano,et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.
[33] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[34] A. Thiel,et al. The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1 , 2004, Molecular and Cellular Biology.
[35] P. Krammer,et al. Death receptors in chemotherapy and cancer , 2004, Oncogene.
[36] Andrew D. Chisholm,et al. Distinct Innate Immune Responses to Infection and Wounding in the C. elegans Epidermis , 2008, Current Biology.
[37] P. LoRusso,et al. Clinical experience of MEK inhibitors in cancer therapy. , 2007, Biochimica et biophysica acta.
[38] J. Pouysségur,et al. ERK implication in cell cycle regulation. , 2007, Biochimica et biophysica acta.
[39] Michal Linial,et al. Using Bayesian Networks to Analyze Expression Data , 2000, J. Comput. Biol..
[40] Erik Willems,et al. Standardization of real-time PCR gene expression data from independent biological replicates. , 2008, Analytical biochemistry.
[41] E. Kiss-Toth,et al. Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific. , 2006, Immunology letters.
[42] Alan R. Saltiel,et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo , 1999, Nature Medicine.
[43] D. Stacey. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. , 2003, Current opinion in cell biology.
[44] S. Akira,et al. Control of Adipose Tissue Inflammation Through TRB1 , 2010, Diabetes.
[45] A. Thiel,et al. The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. , 2004, Molecular and cellular biology.
[46] A. Adjei,et al. Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy , 2008, Clinical Cancer Research.
[47] W. Greene,et al. p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* , 2004, Journal of Biological Chemistry.
[48] B. Bonavida,et al. Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis , 2011, Cell cycle.
[49] S. Dower,et al. Human Tribbles, a Protein Family Controlling Mitogen-activated Protein Kinase Cascades* , 2004, Journal of Biological Chemistry.
[50] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[51] F. McCormick,et al. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.
[52] Tanya Cashorali,et al. Causal Modeling Using Network Ensemble Simulations of Genetic and Gene Expression Data Predicts Genes Involved in Rheumatoid Arthritis , 2011, PLoS Comput. Biol..
[53] C. Lawrence,et al. A statistical sampling algorithm for RNA secondary structure prediction. , 2003, Nucleic acids research.
[54] M. McMahon,et al. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1. , 2005, Cancer research.
[55] J. Baldassare,et al. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. , 1997, The Biochemical journal.
[56] Terence P. Speed,et al. Bayesian Inference of Signaling Network Topology in a Cancer Cell Line , 2012, Bioinform..
[57] Carlotta Costa,et al. MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. , 2012, Cancer research.